Endothelins in the microvasculature and heart in diabetes

Advances in Experimental Medicine and Biology

Volumn 498, Issue , 2001, Pages 97-108

  Chakrabarti, Subrata ^a   Chen, Shali ^a   Evans, Terry ^a   Karmazyn, Morris ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN DERIVATIVE; PROTEIN KINASE C; VASOACTIVE AGENT;

CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; ENZYME ACTIVITY; HEART DISEASE; HUMAN; HYPERGLYCEMIA; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0035701632     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-1321-6_13     Document Type: Conference Paper

References (88)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes ellitus
2. Hyperglycemic pseudohypoxia and diabetic complications
3. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease
4. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications
5. Abnormalities of vascular endothelium in diabetes
6. Protein kinase C activation and the development of diabetic complications
7. Cardiac consequences of diabetes mellitus
8. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?
9. Diabetic cardiomyopathy: An overview
10. Effect of Iovastatin on early carotid atherosclerosis and cardiovascular events
11. Diabetes and atherosclerosis: An epidemiologic view
12. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
13. Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations?
14. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor
15. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus
16. Prognosis of patients with diabetes mellitus after acute myocardial infarction
17. Diabetes mellitus and its degenerative complications. A prospective study of 4400 patients observed between 1947 and 1973
18. Nonenzymatic browning of proteins and the sorbitol pathway
19. Biochemical and molecular mechanisms in the development of diabetic vascular complications
20. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation
21. Effect of verapamil on cardiac protein kinase C activity in diabetic rats
22. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells
23. +-ATPase
24. Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue
25. Glucose induced genes in bovine aortic smooth muscle cells identified by mRNA differential display
26. Identification of multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose by using mRNA differential display
27. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
28. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation
29. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose
30. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor
31. Endothelin-1. A matter of life and breath
32. Endothelins: Multifunctional renal peptides
33. The endothelium and control of blood vessel function in health and disease
34. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology
35. The structure and specificity of endothelin receptors: Their importance in physiology and medicine
36. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1
37. Endothelin in rabbit uterus during pregnancy
38. Mechanisms involved in the stimulation of aldosterone production by angiotensin II, vasopressin and endothelin
39. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1
40. Endothelins as cardiovascular peptides
41. Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells
42. Endothelin-1 is produced and secreted by neontal rat cardiac myocytes in vitro
43. Endothelin has potent inotropic effects in rat atria
44. Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide
45. Cardiac and renal endothelin-1 binding sites in streptozotocin-induced diabetic rats
46. Expression of preproEndothelin-1 mRNA in streptozotocin-induced diabetic rats
47. Changes in the responsiveness to endothelin-1 in isolated atria from diabetic rats
48. Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli
49. Interaction between endothelin and endothelial derived relaxing factors
50. +-ATPase activity by a protein kinase C-dependent pathway in rabbit aorta
51. Down-regulation of endothelin-1 receptors by protein kinase C in streptozotocin diabetic rats
52. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: Influence of tocopherol as antioxidant
53. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor
54. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion
55. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart
56. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy
57. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation
58. Diabetes induced vascular dysfunction in the retina: Role of endothelins
59. Endothelins, their receptors, and retinal vascular dysfunction in galactose-fed rats
60. Production of endothelin 1 by cultured bovine retinal endothelial cells and presence of endothelin receptors on associated pericytes
61. Ocular effects of the endothelins. Abundant peptides in the eye
62. Endothelin: Visualization of mRNAs by in situ hybridization provides evidence for local action
63. Molecular characterization of endothelin receptors and the effect of insulin on their expression in retinal microvascular pericytes
64. Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes
65. Immunoreactive endothelin distribution in ocular tissues
66. Endothelin-1 and endothelin-3-like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats
67. The cellular and molecular mechanisms of diabetic complications
68. Endothelin induces transcription of fos/jun family genes: A prominent role for calcium ion
69. Endothelin-1 stimulates DNA synthesis and anchorage-independent growth of Rat-1 fibroblasts through a protein kinase C-dependent mechanism
70. Stimulation of phosphatidylinositol hydrolysis, diacylglycerol release, and gene expression in response to endothelin, a potent new agonist for fibroblasts and smooth muscle cells
71. Differential regulation of fos and jun gene expression and AP-1 cis-element activity by endothelin isopeptides. Possible implications for mitogenic signaling by endothelin
72. Anionic sites in diabetic basement membranes and their possible role in diffusion barrier abnormalities in the BB-rat
73. Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats
74. Hyperhexosemia induced extracellular matrix protein gene expression and basement membrane thickening in the retinal microvasculature are mediated via augmented endothelin production
75. Vascular endothelial growth factor increases endothelin-converting enzyme expression in vascular endothelial cells
76. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats
77. Impairment of endothelium dependent relaxation in the diabetic rat heart: Mechanisms and implications
78. Free radicals, nitric oxide and diabetic complications
79. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat
80. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
81. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy
82. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth
83. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas
84. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues
85. Protein kinase C and its substrates